Dipeptidyl Peptidase IV Activated Near-Infrared Fluorescent Probe for Visually Evaluating Diabetes Models under

Xiao Sun1,2, Yan Huang1, Lili Fu3,4

  • 1School of Pharmacy, Binzhou Medical University, Yantai 264003, China.

Analytical Chemistry
|November 21, 2025
PubMed

Insights

Microplastics (MPs) may harm type 2 diabetes mellitus (T2DM) patients. A new fluorescent probe, Cy-DPP, detected increased DPP4 levels in T2DM models exposed to MPs, aiding diagnosis and MP toxicity research.

Area of Science:

  • Environmental Health
  • Biochemistry
  • Medical Diagnostics

Background:

  • Microplastics (MPs) pose environmental health risks, but their impact on type 2 diabetes mellitus (T2DM) is understudied in relevant models.
  • Dipeptidyl peptidase IV (DPP4/CD26) activity is linked to T2DM development, making it a target for diagnosis and toxicity studies.

Purpose of the Study:

  • To develop a noninvasive method for monitoring DPP4 activity in microplastic-exposed models.
  • To investigate the differential effects of microplastics on DPP4 levels in healthy versus T2DM individuals.

Main Methods:

  • Development of an enzyme-activatable near-infrared fluorescent probe (Cy-DPP).
  • Application of Cy-DPP to detect DPP4 activity in microplastic-exposed cells and mouse models (healthy and T2DM).

Main Results:

  • The Cy-DPP probe successfully monitored DPP4 activity in response to microplastic exposure.
  • Differential upregulation of DPP4 was observed in T2DM cells and mouse models compared to healthy controls after microplastic exposure.

Conclusions:

  • The study introduces Cy-DPP as a novel tool for early T2DM diagnosis and microplastic toxicity assessment.
  • Microplastics significantly impact DPP4 levels, particularly in type 2 diabetes mellitus contexts, highlighting potential health risks for diabetic populations.